This selectivity is theoretically advantageous because it avoids the hyperglycemia, carpal tunnel syndrome, and insulin resistance associated with systemic GH therapy
As this was happening, career FDA scientists quietly argued in posts shared on the FDA website that there had not yet been enough clinical human trials to confirm that the peptides in question are both safe and effective for pharmacies to compound and distribute
no LD50 established even at very high doses in rodents No Hormonal Effects: Does not affect testosterone, estrogen, growth hormone, or other hormonal axes Gastric Origin: Derived from a naturally occurring human gastric protein, suggesting good biological compatibility Stability: Unusually stable in gastric acid, supporting oral administration potential Reported Effects: Anecdotal reports of fatigue, nausea in some research subjects TB-500 Safety Profile: (PMID: 20536472) Note: Published safety data is primarily available for Thymosin Beta-4
The total cost of peptide therapy varies based on the specific peptides prescribed, the recommended protocol, dosage requirements, and the duration of treatment
Also, depending on where they are procured (for example, directly from foreign manufacturers or via online influencers affiliate links), they also pose the risk of being inconsistent in terms of dosing and purity, which comes with inherent safety risks
